Clinical Study "Common" Name (formal title)	Number of enrollees	Funding source (pharma/NIH)	Year complete	Primary publication	Full study treatment protocol
T-REX	60	Genentech	2017	Year 2: Wykoff CC, Ou WC, Brown DM, et al. Randomized trial of treat-and-extend versus monthly dosing for neovascular age-related macular degeneration: 2-year results of the TREX-AMD study. Ophthalmol Retina. 2017;1:314-321. https://ophthalmologyretina.org/article/S2468-6530(16)30104-X/abstract Year 3: Wykoff CC, Ou WC, Croft DE, et al. Neovascular age-related macular degeneration management in the third year: Final results from the TREX-AMD randomized trial. Br J Ophthalmol. 2018;102:460-464. https://bjo.bmj.com/content/102/4/460.long	N/A